Cargando…

Bone mineral density in Palestinian patients with end-stage renal disease and the related clinical and biochemical factors: Cross-sectional study

INTRODUCTION: End-Stage Renal Disease (ESRD) is the ultimate result of chronic kidney disease (CKD). In Palestine, the prevalence of ESRD was 240.3 PMP which is comparable with the nearby countries. Accelerated bone loss among ESRD patients is attributed to abnormal bone turn over that leads to oste...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazzal, Zaher, Khader, Shahd, Zawyani, Hiba, Abdallah, Mazen, Sawalmeh, Osama, Hamdan, Zakaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661051/
https://www.ncbi.nlm.nih.gov/pubmed/33180791
http://dx.doi.org/10.1371/journal.pone.0241201
_version_ 1783609137935941632
author Nazzal, Zaher
Khader, Shahd
Zawyani, Hiba
Abdallah, Mazen
Sawalmeh, Osama
Hamdan, Zakaria
author_facet Nazzal, Zaher
Khader, Shahd
Zawyani, Hiba
Abdallah, Mazen
Sawalmeh, Osama
Hamdan, Zakaria
author_sort Nazzal, Zaher
collection PubMed
description INTRODUCTION: End-Stage Renal Disease (ESRD) is the ultimate result of chronic kidney disease (CKD). In Palestine, the prevalence of ESRD was 240.3 PMP which is comparable with the nearby countries. Accelerated bone loss among ESRD patients is attributed to abnormal bone turn over that leads to osteoporosis and osteopenia. The risk of fractures is increased four-fold in men and women on hemodialysis, which explains the importance of assessing the bone mineral density among these population. The goals of this study were to find the prevalence of osteoporosis in ESRD patients as determined by bone mineral density (BMD) at different sites and to determine whether BMD correlates with many other clinical parameters. METHODS: A cross-sectional study of 194 ESRD patients were recruited from the dialysis unit in An-Najah National University Hospital, Nablus, Palestine. The patients were on regular hemodialysis or peritoneal dialysis. BMD was measured at the lumbar spine and the hip using the dual-energy X-Ray absorptiometry (DEXA) and the value is expressed as T-score. The data were analyzed using SPSS, version 26. The relationship between BMD and the clinical and biochemical parameters among the ESRD patients was assessed. RESULTS: We found that 42.8% of ESRD patient had osteoporosis and 40.2% had osteopenia. There were significantly higher proportions of osteoporosis and osteopenia among patients >60 years of age (p<0.005). Patients with osteoporosis and osteopenia had significantly higher serum levels of PTH (792.9 and 469.7) (p<0.05). BMD decreases as the duration of dialysis (39.0 months Vs. 56.8 months), (p<0.05). We found no significant difference between patients on hemodialysis or peritoneal dialysis. CONCLUSION: This study showed that Palestinian patients with ESRD have low BMD at the hip and spine. The observed high serum level of PTH was associated with low BMD. Those patients should be closely monitored especially those with more than one risk factor. Moreover, more attention should be paid for these category of patients to decrease the incidence of falling down and the resulting fractures that might lead to mortality and morbidity.
format Online
Article
Text
id pubmed-7661051
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-76610512020-11-18 Bone mineral density in Palestinian patients with end-stage renal disease and the related clinical and biochemical factors: Cross-sectional study Nazzal, Zaher Khader, Shahd Zawyani, Hiba Abdallah, Mazen Sawalmeh, Osama Hamdan, Zakaria PLoS One Research Article INTRODUCTION: End-Stage Renal Disease (ESRD) is the ultimate result of chronic kidney disease (CKD). In Palestine, the prevalence of ESRD was 240.3 PMP which is comparable with the nearby countries. Accelerated bone loss among ESRD patients is attributed to abnormal bone turn over that leads to osteoporosis and osteopenia. The risk of fractures is increased four-fold in men and women on hemodialysis, which explains the importance of assessing the bone mineral density among these population. The goals of this study were to find the prevalence of osteoporosis in ESRD patients as determined by bone mineral density (BMD) at different sites and to determine whether BMD correlates with many other clinical parameters. METHODS: A cross-sectional study of 194 ESRD patients were recruited from the dialysis unit in An-Najah National University Hospital, Nablus, Palestine. The patients were on regular hemodialysis or peritoneal dialysis. BMD was measured at the lumbar spine and the hip using the dual-energy X-Ray absorptiometry (DEXA) and the value is expressed as T-score. The data were analyzed using SPSS, version 26. The relationship between BMD and the clinical and biochemical parameters among the ESRD patients was assessed. RESULTS: We found that 42.8% of ESRD patient had osteoporosis and 40.2% had osteopenia. There were significantly higher proportions of osteoporosis and osteopenia among patients >60 years of age (p<0.005). Patients with osteoporosis and osteopenia had significantly higher serum levels of PTH (792.9 and 469.7) (p<0.05). BMD decreases as the duration of dialysis (39.0 months Vs. 56.8 months), (p<0.05). We found no significant difference between patients on hemodialysis or peritoneal dialysis. CONCLUSION: This study showed that Palestinian patients with ESRD have low BMD at the hip and spine. The observed high serum level of PTH was associated with low BMD. Those patients should be closely monitored especially those with more than one risk factor. Moreover, more attention should be paid for these category of patients to decrease the incidence of falling down and the resulting fractures that might lead to mortality and morbidity. Public Library of Science 2020-11-12 /pmc/articles/PMC7661051/ /pubmed/33180791 http://dx.doi.org/10.1371/journal.pone.0241201 Text en © 2020 Nazzal et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Nazzal, Zaher
Khader, Shahd
Zawyani, Hiba
Abdallah, Mazen
Sawalmeh, Osama
Hamdan, Zakaria
Bone mineral density in Palestinian patients with end-stage renal disease and the related clinical and biochemical factors: Cross-sectional study
title Bone mineral density in Palestinian patients with end-stage renal disease and the related clinical and biochemical factors: Cross-sectional study
title_full Bone mineral density in Palestinian patients with end-stage renal disease and the related clinical and biochemical factors: Cross-sectional study
title_fullStr Bone mineral density in Palestinian patients with end-stage renal disease and the related clinical and biochemical factors: Cross-sectional study
title_full_unstemmed Bone mineral density in Palestinian patients with end-stage renal disease and the related clinical and biochemical factors: Cross-sectional study
title_short Bone mineral density in Palestinian patients with end-stage renal disease and the related clinical and biochemical factors: Cross-sectional study
title_sort bone mineral density in palestinian patients with end-stage renal disease and the related clinical and biochemical factors: cross-sectional study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661051/
https://www.ncbi.nlm.nih.gov/pubmed/33180791
http://dx.doi.org/10.1371/journal.pone.0241201
work_keys_str_mv AT nazzalzaher bonemineraldensityinpalestinianpatientswithendstagerenaldiseaseandtherelatedclinicalandbiochemicalfactorscrosssectionalstudy
AT khadershahd bonemineraldensityinpalestinianpatientswithendstagerenaldiseaseandtherelatedclinicalandbiochemicalfactorscrosssectionalstudy
AT zawyanihiba bonemineraldensityinpalestinianpatientswithendstagerenaldiseaseandtherelatedclinicalandbiochemicalfactorscrosssectionalstudy
AT abdallahmazen bonemineraldensityinpalestinianpatientswithendstagerenaldiseaseandtherelatedclinicalandbiochemicalfactorscrosssectionalstudy
AT sawalmehosama bonemineraldensityinpalestinianpatientswithendstagerenaldiseaseandtherelatedclinicalandbiochemicalfactorscrosssectionalstudy
AT hamdanzakaria bonemineraldensityinpalestinianpatientswithendstagerenaldiseaseandtherelatedclinicalandbiochemicalfactorscrosssectionalstudy